Tazarotene as alternative topical treatment for onychomycosis

References

• WesterbergDPVoyackMJOnychomycosis. Current trends in diagnosis and treatmentAm Fam Physician2013881176277024364524
   PubMed Web of Science ®Google Scholar
• KaurRKashyapBBhallaPOnychomycosis – epidemiology, diagnosis and managementIndian J Med Microbiol200826210811618445944
   PubMed Web of Science ®Google Scholar
• ChiCCWangSHChouMCThe causative pathogens of onychomycosis in southern TaiwanMycoses200548641342016262878
   PubMed Web of Science ®Google Scholar
• DrakeLADinehartSMFarmerERGuidelines of care for superficial mycotic infections of the skin: tinea corporis, tinea cruris, tinea faciei, tinea manuum, and tinea pedis. Guidelines/outcomes committee. American academy of dermatologyJ Am Acad Dermatol1996342 pt 12822868642094
   PubMed Web of Science ®Google Scholar
• ScherRKDiseases of the nailsConnHCurrent TherapyPhiladelphia, PAThe W. B. Saunders Co1990736742
   Google Scholar
• TostiAHayRArenas-GuzmanRPatients at risk of onychomycosis – risk factor identification and active preventionJ Eur Acad Dermatol Venereol200519suppl 1131616120200
   PubMed Web of Science ®Google Scholar
• DiasNSantosCPortelaMLimaNToenail onychomycosis in a Portuguese geriatric populationMycopathologia20111721556121365319
   PubMed Web of Science ®Google Scholar
• LeiboviciVHershkoKIngberAWestermanMLeviatan-StraussNHochbergMIncreased prevalence of onychomycosis among psoriatic patients in IsraelActa Derm Venereol2008881313318176747
   PubMed Web of Science ®Google Scholar
• ScherRKTavakkolASigurgeirssonBOnychomycosis: diagnosis and definition of cureJ Am Acad Dermatol200756693994417307276
   PubMed Web of Science ®Google Scholar
• DrakeLADinehartSMFarmerERGuidelines of care for superficial mycotic infections of the skin: pityriasis (tinea) versicolor. Guidelines/outcomes committee. American academy of dermatologyJ Am Acad Dermatol1996342 pt 12872898642095
   PubMed Web of Science ®Google Scholar
• ScherRKOnychomycosis: a significant medical disorderJ Am Acad Dermatol1996353 pt 2S2S58784302
   PubMed Web of Science ®Google Scholar
• ElewskiBEOnychomycosis: pathogenesis, diagnosis, and managementClin Microbiol Rev19981134154299665975
   PubMed Web of Science ®Google Scholar
• PiracciniBMGianniCUpdate on the management of onychomycosisG Ital Dermatol Venereol2013148663363824442043
   PubMed Web of Science ®Google Scholar
• CrawfordFHollisSTopical treatments for fungal infections of the skin and nails of the footCochrane Database Syst Rev2007183CD00143417636672
   PubMedGoogle Scholar
• DiluvioLCampioneEPaternoEJMordentiCEl HachemMChimentiSChildhood nail psoriasis: a useful treatment with tazarotene 0.05%Pediatr Dermatol200724333233317542899
   PubMed Web of Science ®Google Scholar
• BianchiLSodaRDiluvioLChimentiSTazarotene 0.1% gel for psoriasis of the fingernails and toenails: an open, prospective studyBr J Dermatol2003149120720912890227
   PubMed Web of Science ®Google Scholar
• EpsteinELStein GoldLSafety and efficacy of tazarotene foam for the treatment of acne vulgarisClin Cosmet Investig Dermatol20136123125
   Google Scholar
• GregoriouSKritsotakiEKatoulisARigopoulosDUse of tazarotene foam for the treatment of acne vulgarisClin Cosmet Investig Dermatol20147165170
   PubMedGoogle Scholar
• IraciSBianchiLGattiSCarrozzoAMBettiniDNiniGPachyonychia congenita with late onset of nail dystrophy – a new clinical entity?Clin Exp Dermatol19931854784808252777
   PubMed Web of Science ®Google Scholar
• HarrisKHullPRHansenCDTransgrediens pachyonychia congenita (PC): case series of a nonclassical PC presentationBr J Dermatol2012166112412821790523
   PubMed Web of Science ®Google Scholar
• KlaassenKMvan de KerkhofPCBastiaensMTPlusjeLGBaranRLPaschMCScoring nail psoriasisJ Am Acad Dermatol20147061061106624698704
   PubMed Web of Science ®Google Scholar
• ElewskiBERichPPollakREfinaconazole 10% solution in the treatment of toenail onychomycosis: two phase III multicenter, randomized, double-blind studiesJ Am Acad Dermatol201368460060823177180
   PubMed Web of Science ®Google Scholar
• SipponenPSipponenALohiJSoiniMTapanainenRJokinenJJNatural coniferous resin lacquer in treatment of toenail onychomycosis: an observational studyMycoses201356328929623131104
   PubMed Web of Science ®Google Scholar
• KnowlesRCMooreTDQuality control of agar diffusion susceptibility tests. Data from the quality assurance service microbiology program of the college of American pathologistsAm J Clin Pathol1980744 suppl5815856776805
   PubMed Web of Science ®Google Scholar
• HayRJFungal skin infectionsArch Dis Child1992679106510671417045
   PubMed Web of Science ®Google Scholar
• DorschnerRALopez-GarciaBMassieJKimCGalloRLInnate immune defense of the nail unit by antimicrobial peptidesJ Am Acad Dermatol200450334334814988673
   PubMed Web of Science ®Google Scholar
• ItoTMeyerKCItoNPausRImmune privilege and the skinCurr Dir Autoimmun200810275218460879
   PubMedGoogle Scholar
• Del RossoJQThe role of topical antifungal therapy for onychomycosis and the emergence of newer agentsJ Clin Aesthet Dermatol201477101825053979
   PubMedGoogle Scholar
• De CuyperCHindryckxPHLong-term outcomes in the treatment of toenail onychomycosisBr J Dermatol1999141suppl 56152010730909
   PubMedGoogle Scholar
• ChangCHYoung-XuYKurthTOravJEChanAKThe safety of oral antifungal treatments for superficial dermatophytosis and onychomycosis: a meta-analysisAm J Med2007120979179817765049
   PubMed Web of Science ®Google Scholar
• SubissiAMontiDTogniGMaillandFCiclopirox: recent nonclinical and clinical data relevant to its use as a topical antimycotic agentDrugs201070162133215220964457
   PubMed Web of Science ®Google Scholar
• EpsteinEHow often does oral treatment of toenail onychomycosis produce a disease-free nail? An analysis of published dataArch Dermatol199813412155115549875192
   PubMedGoogle Scholar
• GuptaAKPaquetMEfinaconazole 10% nail solution: a new topical treatment with broad antifungal activity for onychomycosis monotherapyJ Cutan Med Surg201418315115524800702
   PubMed Web of Science ®Google Scholar
• DiasMFQuaresma-SantosMVBernardes-FilhoFAmorimAGSchechtmanRCAzulayDRUpdate on therapy for superficial mycoses: review article part IAn Bras Dermatol201388576477424173183
   PubMed Web of Science ®Google Scholar
• KlaassenKMDulakMGvan de KerkhofPCPaschMCThe prevalence of onychomycosis in psoriatic patients: a systematic reviewJ Eur Acad Dermatol Venereol201428553354124033871
   PubMed Web of Science ®Google Scholar
• BianchiLOrlandiACampioneETopical treatment of basal cell carcinoma with tazarotene: a clinicopathological study on a large series of casesBr J Dermatol2004151114815615270884
   PubMed Web of Science ®Google Scholar
• ThacherSMVasudevanJChandraratnaRATherapeutic applications for ligands of retinoid receptorsCurr Pharma Des2000612558
   PubMed Web of Science ®Google Scholar
• OrlandiABianchiLCostanzoACampioneEGiusto SpagnoliLChimentiSEvidence of increased apoptosis and reduced proliferation in basal cell carcinomas treated with tazaroteneJ Invest Dermatol200412241037104115102095
   PubMed Web of Science ®Google Scholar
• BushueNWanYJRetinoid pathway and cancer therapeuticsAdv Drug Deliv Rev201062131285129820654663
   PubMed Web of Science ®Google Scholar
• LotanRRetinoids in cancer chemopreventionFASEB J1996109103110398801164
   PubMed Web of Science ®Google Scholar
• CervelliVScioliMGGentilePPlatelet-rich plasma greatly potentiates insulin-induced adipogenic differentiation of human adipose-derived stem cells through a serine/threonine kinase Akt-dependent mechanism and promotes clinical fat graft maintenanceStem Cells Transl Med20121320622023197780
   PubMed Web of Science ®Google Scholar
• GuptaAKDaigleDPaquetMTherapies for onychomycosis: a systematic review and network meta-analysis of mycological cureJ Am Podiatr Medl Assoc Epub2014717
   Web of Science ®Google Scholar